drugset / Trial / NCT06896994
Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia
Recruiting
150 enrolled
Beijing Tiantan Hospital
Beijing Ditan Hospital · collabBeijing Xiaotangshan Hospital · collabHengshui People's Hospital · collabThe First Hospital of Fangshan District,Beijing · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
To assess the 1-week effects and safety of esketamine in combination with pregabalin and duloxetine to relieve pain in patients with postherpetic Neuralgia(PHN).
Timeline
- Start
- 2025-04-01
- Primary completion
- 2026-04-01
- Completion
- 2026-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 8 mg | Intravenous |
| Background | Duloxetine | Small molecule | 60 mg | — |
| Background | Pregabalin | Small molecule | 600 mg | — |